DEERFIELD, Ill. — Walgreens and Kaléo announced Thursday AUVI-q (epinephrine injection, USP) 0.1 mg auto-injector is available at Walgreens locations nationwide. AUVI-q 0.1 mg is the first and only epinephrine auto-injector (EAI) approved by the U.S. Food and Drug Administration (FDA) for infants and toddlers weighing 16.5 to 33 pounds (7.5 to 15 kilograms). Through
DEERFIELD, Ill. and RICHMOND, Va. — Walgreens and kaléo, a privately-held pharmaceutical company, are working together to improve access to epinephrine auto-injectors by making kaléo’s AUVI-Q 0.15 mg and 0.3 mg available through Walgreens locations nationwide. This comes in an effort to help thousands of Americans with their epinephrine needs during the back to school
RICHMOND, Va. — Next year, Kaleo plans to release Auvi-Q 0.1 mg, a version of its epinephrine auto-injector for infants and small children. Kaleo said Monday that the Food and Drug Administration has approved its supplemental New Drug Application (sNDA) for Auvi-Q 0.1 mg, which can be used to treat life-threatening allergic reactions, including anaphylaxis,
WOONSOCKET, R.I. — In the wake of the public outcry over pricing for Mylan’s EpiPen epinephrine auto-injector for anaphylaxis, CVS Health announced that it’s providing a low-cost alternative. CVS said Thursday that Impax Laboratories’ authorized generic for the Adrenaclick epinephrine auto-injector is now available at all CVS Pharmacy drug stores at a cash price of $109.99
RICHMOND, Va. — Pharmaceutical company Kaleo plans to reintroduce the Auvi-Q epinephrine auto-injector to the U.S. market in the first half of 2017. For emergency use in treating life-threatening allergic reactions such as anaphylaxis, Auvi-Q is expected to provide an option to the EpiPen from Mylan Inc., which has been lambasted by government officials, the
